Trial intelligence / Profile preview

Glecaprevir/Pibrentasvir + Sofosbuvir + Ribavirin in prior AbbVie HCV DAA failures

CTR20201304Phase 3Completed

Sponsor

AbbVie Inc.

Start

Sep 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1